Craig Rumbaugh
Pain Medicine · Albuquerque, NMNPI 1184019127
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (56.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Medtronic at 34.1% of the total. Reporting peaked in 2019 at $7,422 and has fallen 91.5% since, to $631 in 2025. Among pain medicine clinicians in NM with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 187 payments — averaging $58.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Abbott$3K
- Boston Scientific$3K
- AbbVie$656
- Scilex Pharmaceuticals Inc.$235
- Biodelivery Sciences International, Inc.$114
- plus $335 from 7 others
What the payments were for
- Grants$6,25057%
- Travel & lodging$9348%
- Food & beverage$3,80235%
- Education$210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 1 | $3,750 |
| Abbott | 98 | $3,417 |
| Boston Scientific | 1 | $2,500 |
| AbbVie(2 entities) | 51 | $656 |
| Scilex Pharmaceuticals Inc. | 12 | $235 |
| Biodelivery Sciences International, Inc. | 11 | $114 |
| Nevro Corp. | 2 | $104 |
| Lilly USA, LLC | 5 | $75 |
| Biohaven Pharmaceuticals, Inc. | 2 | $54 |
| Avanos Medical | 1 | $34 |
| Tonix Medicines, Inc. | 1 | $25 |
| Pfizer | 1 | $22 |
| Hikma Pharmaceuticals USA | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMED$3,750
- SPECTRA WAVEWRITER$2,500
- Proclaim Family of SCS IPGs$1,174
- Proclaim IPG$439
- ETERNA$292
- UBRELVY$104
How this compares
$11,007 in reported general payments places this provider in the 95th percentile of 36 pain medicine providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 113 | $95,692 |
| ReyvowLasmiditan Succinate | 13 | $75,687 |
| Nurtec OdtRimegepant Sulfate | 11 | $25,706 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 113 | $24,008 |
| BotoxOnabotulinumtoxina | 21 | $21,579 |
| UbrelvyUbrogepant | 11 | $17,687 |
| Buprenorphine Hcl | 243 | $14,868 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 613 | $13,045 |
| Pregabalin | 628 | $10,505 |
| Gabapentin | 484 | $7,008 |
| Hysingla ErHydrocodone Bitartrate | 15 | $5,981 |
| Naloxone Hcl | 65 | $4,654 |
| Diclofenac Sodium | 157 | $3,198 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 105 | $3,031 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 136 | $2,949 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCReyvow | $75 | $75,68713 claims |
| Hikma Pharmaceuticals USABuprenorphine-Naloxone, Buprenorphine Hcl, Morphine Sulfate, Buprenorphine | $21 | $43,374462 claims |
| AbbVieBotox, Ubrelvy | $656 | $39,26632 claims |
| PfizerNurtec Odt | $22 | $25,70611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 36 pain medicine providers in New Mexico.
Other pain medicine in Albuquerque
- John WatkinsAlbuquerque$22K
- Eugene KoshkinAlbuquerque$10K
- Matthew BergstenAlbuquerque$7K
- Lauren HarrisAlbuquerque$6K
- Melissa MerhegeAlbuquerque$5K
- Jeremy ChastainAlbuquerque$5K
- Joshu RaitenAlbuquerque$4K
- Thomas WhalenAlbuquerque$4K
- Matthew ValerianoAlbuquerque$4K
- Umar CheemaAlbuquerque$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.